Cirrhotic Cardiomyopathy: Proportion and Correlation with Liver Fibrosis Severity
Keywords:
Liver cirrhosis, cardiomyopathies, ventricular dysfunction, left, elasticity imaging techniques, echocardiography, doppler, atrial remodelingAbstract
Background: Cirrhotic cardiomyopathy is characterized by an impaired systolic response to stress, diastolic dysfunction, and electrophysiological abnormalities, without underlying structural heart disease. Left ventricular diastolic dysfunction (LVDD) is the most common manifestation found in cirrhotic cardiomyopathy. Previous studies reported its correlation with a higher Child-Turcotte-Pugh (CTP) score in late-stage cirrhosis. To date, no studies have evaluated the correlation between liver fibrosis and LVDD parameters. This study aims to evaluate the correlation between liver fibrosis and LVDD parameters. Methods: We conducted a cross-sectional study on liver cirrhosis patients without a history of cardiac disease. Subjects were recruited consecutively from the Hepatobiliary Outpatient Clinic and Internal Medicine Inpatient Unit at Cipto Mangunkusumo National General Hospital. A total of 92 patients underwent 2-dimensional echocardiography with tissue Doppler imaging, transient elastography, and laboratory tests for routine hematology, ALT, and AST. Results: A total of 27.2% of subjects had diastolic dysfunction, and 37% had normal diastolic function with an increased left atrial volume index. APRI and FIB-4 showed a positive correlation with left atrial volume index (r = 0.302; p = 0.003 vs r = 0.401; p < 0.0001, respectively). FIB-4 demonstrated a fair performance in estimating increased left atrial volume index (AUC 0.746; 95% CI 0.646–0.846), with a cut-off point of 4.38. Conclusion: Diastolic dysfunction is the most common early manifestation found in cirrhotic cardiomyopathy. Liver fibrosis, assessed by APRI and FIB-4, was positively correlated with increased left atrial volume index.References
Nurdjanah S. Sirosis hati. In: Sudoyo AW, Setiyohadi B, Alwi I, K MS, editors. Buku ajar ilmu penyakit dalam. 6th edition. Jakarta: Interna Publishing; 2014. p. 1825–9.
Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388–98.
Izzy MJ, VanWagner LB. Current concepts of cirrhotic cardiomyopathy. Clin Liver Dis. 2021 May;25(2):471–81.
Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014 Jul 11;8(3):308–15.
Glenn TK, Honar H, Liu H, ter Keurs HEDJ, Lee SS. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J Hepatol. 2011 Dec;55(6):1249–55.
Carvalho MVH, Kroll PC, Kroll RTM, Carvalho VN. Cirrhotic cardiomyopathy: the liver affects the heart. Brazilian J Med Biol Res. 2019;52(2).
Mondrowinduro P, Hasan I, Alwi I, Abdullah M. Left ventricular diastolic dysfunction in liver cirrhotic patients: Proportion, correlation, and relationship of diastolic parameters with stage of liver dysfunction. J Penyakit Dalam Indones. 2018;5(1):2–10.
Solanki R, Sreesh S, Attumalil TV, et al. A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver–heart axis. Ann Gastroenterol. 2023;36(6):678–85.
Ruiz-del-Árbol L, Achécar L, Serradilla R, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatology. 2013 Nov;58(5):1732–41.
Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26(5):1131–7.
Izzy M, VanWagner LB, Lin G, et al. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology. 2020;71(1):334–45.
Al Atroush HH, Mohammed KH, Nasr FM, Al Desouky MI, Rabie MA. Cardiac dysfunction in patients with end-stage liver disease, prevalence, and impact on outcome: a comparative prospective cohort study. Egypt Liver J. 2022;12(1).
Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatol Int. 2014;8(4):588–94.
Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography q. 2008;48:835–47.
Duarte-rojo A, Patel K, Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension. 2024;40(3):148–55.
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.
Mansoor H, Khizer M, Afreen A, et al. Systolic and diastolic impairment in cirrhotic cardiomyopathy: insights from a cross-sectional study. Egypt Liver J. 2024 Jul 19;14(1):60.
Razpotnik M, Bota S, Wimmer P, et al. The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria. Hernandez‐Gea V, editor. Liver Int. 2021 May 2;41(5):1058–69.
Behera SK, Behera P, Behera JR, Behera G. Study of cardiac dysfunction in portal hypertension: A single-center experience from Eastern India. Cureus. 2023;15(12).
Farouk H, Al-Maimoony T, Nasr A, El-Serafy M, Abdel-Ghany M. Echocardiographic assessment of the left ventricular diastolic function in patients with non-alcoholic liver cirrhosis. Cor Vasa. 2017;59(6):e540–5.
Cesari M, Frigo AC, Tonon M, Angeli P. Cardiovascular predictors of death in patients with cirrhosis. Hepatology. 2018 Jul;68(1):215–23.
Merli M, Torromeo C, Giusto M, Iacovone G, Riggio O, Puddu PE. Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass. Liver Int. 2017 May 19;37(5):700–6.
Biteker M, Kayataş K, Başaran Ö, Doğan V, Özlek E, Özlek B. The role of left atrial volume index in patients with a first-ever acute ischemic stroke. J Stroke Cerebrovasc Dis. 2017 Feb;26(2):321–6.
Parikh ND, Mehta M, Tapper EB. FIB-4 and APRI for cirrhosis detection in a privately insured national cohort. JHEP Reports. 2024 Jan;6(1):100925.
Machado FR, Cavalcanti AB, Monteiro MB, et al. Predictive accuracy of the quick sepsis-related organ failure assessment score in Brazil. A prospective multicenter study. Am J Respir Crit Care Med. 2020 Apr 1;201(7):789–98.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Juferdy Kurniawan, Maela Rustiana Dewi, Dono Antono, Dicky Levenus Tahapary, Leonard Nainggolan, Gurmeet Singh, M. Syahrir Azizi, Rudi Putranto, Kaka Renaldi, Sukamto Sukamto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
